Skip to content
value.today

Analyte Health, Inc.

🇺🇸 Chicago, Illinois, USATechnologyFounded 2008
Total raised
$20 M
4 rounds on record
Latest round
$3 M
Sep 2017
First round on record
Jun 2010
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Analyte Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2017$3 MNo. 4$2 to $10 million

Analyte Health, Inc.: Raise no. 4, Sep 2017

Investors in this round

3 investors had bought by the notice of Sep 29, 2017: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Franklin Cockerill III · Executive Officer, Director
  • Kevin Weinstein · Executive Officer, Director
  • Adam Koopersmith · Director
  • Lon Chow · Director
  • Phyllis Whiteley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kevin Weinstein, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 29, 2017. Read the notice at the SEC.

equitySEC
Feb 2016$7 MNo. 3$2 to $10 million

Analyte Health, Inc.: Raise no. 3, Feb 2016

Investors in this round

3 investors had bought by the notice of Feb 12, 2016: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Franklin Cockerill III · Executive Officer, Director
  • Adam Koopersmith · Director
  • Lon Chow · Director
  • Phyllis Whiteley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Franklin Cockerill III, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2016. Read the notice at the SEC.

equitySEC
Jun 2012$8 MNo. 2$2 to $10 million

Analyte Health, Inc.: Raise no. 2, Jun 2012

Investors in this round

5 investors had bought by the notice of Jul 11, 2012: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Shares of Series C Preferred Stock and the common stock issuable upon conversion.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Malven · Executive Officer, Director
  • Sridhar Murthy · Executive Officer, Director
  • Lon Chow · Director
  • Matthew McCall · Director
  • Vance Vanier · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”

Signed by Sridhar Murthy, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 11, 2012. Read the notice at the SEC.

equitySEC
Jun 2010$3 MNo. 1$2 to $10 million

Analyte Health, Inc.: Raise no. 1, Jun 2010

Investors in this round

12 investors had bought by the notice of May 17, 2011: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, other: Secured Convertible Notes
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Malven · Executive Officer, Director
  • Michelle Sobel · Executive Officer, Director
  • Sridhar Murthy · Executive Officer, Director
  • Daniel Derman · Director
  • Lon Chow · Director
  • Matthew McCall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”

Signed by Sridhar Murthy, C.e.o.. Source: SEC Form D, newest notice filed May 17, 2011. Read the notice at the SEC.

equity, debt, optionsSEC
Nov 2008$1 MIssued in a merger or acquisitionUnder $2 million

Analyte Health, Inc.: Private sale, Nov 2008

Investors in this round

4 investors had bought by the notice of May 17, 2011: 2 accredited, 2 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Malven · Executive Officer, Director
  • Michelle Sobel · Executive Officer, Director
  • Sridhar Murthy · Executive Officer, Director
  • Daniel Derman · Director
  • Lon Chow · Director
  • Matthew McCall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds to be used as working capital, including payment of director, officer and employee salaries.”
  • On a merger: “Offer was made in connection with acquisition of Ajuga Media LLC's assets.”

Signed by Sridhar Murthy, C.e.o.. Source: SEC Form D, newest notice filed May 17, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Analyte Health, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).

    SEC Form D · Sep 2017

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Sep 2017

That is all the official record says: Analyte Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Analyte Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 12 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Analyte Health, Inc.
NameRoleNamed in
Franklin Cockerill IIIExecutive officerSep 2017
Kevin WeinsteinExecutive officerSep 2017
Daniel MalvenExecutive officerJul 2012
Sridhar MurthyExecutive officerJul 2012
Dan MalvenExecutive officerMay 2011
Michelle SobelExecutive officerMay 2011
Adam KoopersmithDirectorSep 2017
Franklin Cockerill IIIDirectorSep 2017
Kevin WeinsteinDirectorSep 2017
Lon ChowDirectorSep 2017
Phyllis WhiteleyDirectorSep 2017
Daniel MalvenDirectorJul 2012
Matthew McCallDirectorJul 2012
Sridhar MurthyDirectorJul 2012
Vance VanierDirectorJul 2012
Dan MalvenDirectorMay 2011
Daniel DermanDirectorMay 2011
Michelle SobelDirectorMay 2011